Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy
Clicks: 261
ID: 115324
1994
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
81.9
/100
261 views
209 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Visual function in patients with glaucoma, as measured by contrast sensitivity, does improve after beta-blocker therapy. Further, the CSV-1000 is a clinically reliable tool for monitoring these changes.| Reference Key |
gn1994investigativetest-retest
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Pomerance GN;Evans DW;; |
| Journal | investigative ophthalmology & visual science |
| Year | 1994 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
reproducibility of results
contrast sensitivity / physiology*
aged
middle aged
Retrospective Studies
vision
pmid:8056510
g n pomerance
d w evans
betaxolol / therapeutic use
glaucoma
open-angle / drug therapy*
open-angle / physiopathology
levobunolol / therapeutic use
timolol / therapeutic use
vision disorders / diagnosis*
vision tests*
ocular
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.